board of directors

Arch Biopartners Appoints Dr. Patrick Vink as Chairman of the Board

6 days ago talkbio0Tagged Arch Biopartners, board of directors, Chairperson, Claude Allary, kidney therapeutics, Patrick Vink

Arch Biopartners; Patrick Vink; Chairman; Board of Directors; Claude Allary; kidney therapeutics

Jim Lang Appointed to the Board of Directors of Halozyme Therapeutics

1 month ago talkbio0Tagged Appointments, Bench International, Biological Factors, BioVie, board of directors, Corporate governance, drug delivery platform, election, Halozyme Therapeutics, Jim Lang

Jim Lang; Halozyme Therapeutics; Board of Directors; appointment; election; Bench International; biopharmaceutical; drug delivery platform; corporate governance; OptimizeRx; BioVie

Specific Biologics Appoints Dr. Richard Glickman to Board of Directors

1 month ago talkbio0Tagged Biological Factors, Biotechnology, board of directors, Genome Editing, Glickman

Specific Biologics; Richard Glickman; Board of Directors; biotechnology; genome editing

Bruker Adds Diagnostics Leader Jack Phillips to Board of Directors Effective January 2026

2 months ago talkbio0Tagged Accelerate Diagnostics, Appointments, board of directors, Bruker Corporation, Corporate governance, diagnostics industry, Jack Phillips, Roche Diagnostics North America, Ventana Medical Systems * *

Bruker Corporation; Jack Phillips; Board of Directors; appointment; January 1 2026; diagnostics industry; corporate governance; Accelerate Diagnostics; Roche Diagnostics North America; Ventana Medical Systems

Jesper Høiland Joins Alva Therapeutics’ Board of Directors

2 months ago talkbio0Tagged Alva Therapeutics, board of directors, Clinical Development, Diabetes Mellitus, Non-Insulin-Dependent, incretin secretagogue, Novo Nordisk, Obesity, Oral cavity, pharmaceutical commercialization

Alva Therapeutics; Board of Directors; Novo Nordisk; Type 2 diabetes; obesity; oral incretin secretagogue; clinical development; pharmaceutical commercialization

Jesper Høiland Joins Alva Therapeutics’ Board of Directors

2 months ago talkbio0Tagged Alva Therapeutics, board of directors, Clinical Development, Diabetes Mellitus, Non-Insulin-Dependent, incretin secretagogue, Novo Nordisk, Obesity, Oral cavity, pharmaceutical commercialization

Alva Therapeutics; Board of Directors; Novo Nordisk; Type 2 diabetes; obesity; oral incretin secretagogue; clinical development; pharmaceutical commercialization

Vera Therapeutics Appoints James R. Meyers to Its Board of Directors

2 months ago talkbio0Tagged Appointments, Atacicept, Autoimmune Diseases, Biological Factors, biotech executive, board of directors, Gilead Sciences, IGA Glomerulonephritis, IntraBio Ltd., James, Vera Therapeutics

Vera Therapeutics; James R. Meyers; Board of Directors; appointment; biotech executive; IgA nephropathy; atacicept; autoimmune diseases; Gilead Sciences; IntraBio Ltd; biopharmaceutical

Edgewise Therapeutics Appoints Christopher Martin to its Board of Directors

2 months ago talkbio0Tagged Acquisition, Becker Muscular Dystrophy, board of directors, cardiovascular asset, Christopher Martin, commercial, Edgewise Therapeutics, executives, Leadership, Merck, Verona Pharma

Edgewise Therapeutics; Christopher Martin; Board of Directors; biotech executive; commercial leadership; Becker muscular dystrophy; cardiovascular asset; Verona Pharma; Merck acquisition

Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors

2 months ago talkbio0Tagged board of directors, Health care facility, Health Policy, innovation, medical breakthroughs, Patient access, Scott Gottlieb, Technology, United States Food and Drug Administration, UnitedHealth Group

Scott Gottlieb; UnitedHealth Group; Board of Directors; FDA; health policy; innovation; patient access; medical breakthroughs; technology in healthcare

Mikael Dolsten Withdraws Candidacy for Novo Nordisk Board; Bavarian Nordic Chairman Resigns

2 months ago talkbio0Tagged Bavarian Nordic, board of directors, board shake-up, chairman resignation, Danish pharma, Mikael Dolsten, Nordisk, personal reasons, Withdraw (activity)

Mikael Dolsten; Novo Nordisk; board of directors; withdrawal; personal reasons; Novo Nordisk Foundation; board shake-up; Danish pharma; Bavarian Nordic; chairman resignation